fda bpc 157 compounding risk statement Survey: Half of Peptide-Users Aren't Aware of Approval Status FDA Briefing Document Pharmacy Compounding

91 In a three-month trial, 90 subjects with tinnitus were treated with ginkgo extract (60 mg twice daily), betahistine (Serc), or trimetazidine (Vastarel) (a drug that dilates coronary and other peripheral blood vessels, but is not available in the United States)

Its often used for dogs with joint issues, GI sensitivity, or those recovering from injury

Deficiency of B 12 make impossible to produce enough healthy RBCs (Reynolds et al., 1993)

Absolute contraindications: Known allergy to AOD9604 or its components Pregnancy or breastfeeding (insufficient safety data) Active cancer (theoretical concern about growth effects) Severe kidney or liver disease History of severe allergic reactions to peptides Relative contraindications (require careful consideration): Diabetes or impaired glucose tolerance (closer monitoring needed) Heart disease (though no direct cardiac effects are expected) History of eating disorders Major psychiatric conditions Use of multiple medications (possible interactions) Special populations Elderly subjects: May need closer monitoring Start with lower doses Monitor for dehydration Assess kidney function before starting Subjects with diabetes: Monitor blood glucose closely May need adjustment of diabetes medications Watch for hypoglycemia, especially with fasting protocols Consider dosing after meals rather than fasted Subjects with heart disease: Although AOD9604 doesnt directly affect cardiac function, monitor closely Assess baseline cardiac status Monitor blood pressure and heart rate Consider stress testing if appropriate Safety Monitoring Recommendations Researchers using AOD9604 should apply appropriate safety monitoring

113b Juni 2011 Additional References Persistent elevation of plasma vitamin B12 is strongly associated with solid cancer